Presentation DIVES MED AMI 200 stands out as a premium tissue biostimulator engineered to combat advanced signs of aging and facial volume loss. By harnessing the regenerative properties of Poly-L-lactic acid (PLLA), this aesthetic solution actively stimulates the body's natural collagen synthesis. The result is a gradual, natural-looking lifting effect and significant skin quality improvement that can endure for up to 24 months.
Composition
& Rheology Biodegradable Poly-L-lactic acid (PLLA) at an optimized concentration Calibrated microparticles designed to maximize fibroblast stimulation Supplied as a 5ml injectable suspension for high-performance treatments
Indications
This biostimulator is specifically designed for comprehensive facial rejuvenation. It is highly effective for correcting hollow cheeks, lifting sagging temples, and smoothing deep nasolabial folds or marionette lines. Furthermore, it is ideal for patients seeking to address moderate to severe skin laxity and redefine their facial contours with precision.
Dosage Treatment must be administered by a qualified healthcare professional. The volumizing and firming effects develop progressively over 4 to 6 weeks as new collagen is formed. Depending on the patient's individual needs, a complete protocol may involve multiple sessions to achieve optimal results.
Storage Store the vial at room temperature, ensuring it is protected from direct sunlight and freezing conditions. Contraindications Known hypersensitivity to PLLA or any of the product's components Active infections or inflammation at the intended injection sites History of autoimmune diseases Pregnancy or breastfeeding
FAQ
How long do the effects of DIVES MED AMI 200 last? Thanks to its potent collagen-stimulating action, the aesthetic improvements can last up to 24 months after completing the recommended treatment protocol. When will I start seeing results?
While the process is gradual, noticeable improvements in skin texture, elasticity, and volume typically become visible within 4 to 6 weeks post-treatment.
